DDW
Purchase access to the virtual platform, and take advantage of the best parts of the meeting. The site will remain open through Aug. 23. Read more
Colorectal cancer screening (CRC) programs around the world have been disrupted by the COVID-19 pandemic. To explore the impact of disruptions to cancer screening of all types, the COVID-19 and Cancer Global Modelling Consortium was established to inform responses to screening disruptions, guide policymakers, and influence... Read more
Red blood cell transfusions are common in patients who undergo surgery for gastrointestinal (GI) cancer. These patients are at high risk for requiring transfusions because of their underlying malignancy, poor nutrition and previous chemotherapies. Research from the past three decades has shown an association between transfu... Read more
DDW Council Chair, Loren Laine, MD, looks back on this year’s annual meeting and highlights some of the most interesting research presented at the meeting. Read more
With the increased availability of safe and effective treatments for patients with hepatitis C (HCV), Brian L. Pearlman, MD, FACP, FAASLD, AAHIVS, identified five HCV patient populations clinicians should understand how to treat. Read more
Prateek Sharama, MD, provided a checklist for clinicians and organizations as endoscopic services resume post COVID-19 to ensure safe and efficient operation. Read more
Kenneth Wang, MD, reviewed recent innovations in cryotherapy and tissue resection that are improving outcomes for patients with Barrett’s esophagus, especially those who have failed standard therapy. Read more
Joseph C. Anderson, MD, FACG, MHCDS, provided a review of the best time to start and stop screening for colorectal cancer (CRC) to detect the cancer early and to prevent unnecessary screening. Read more
Jacob E. Kurlander, MD, MS, of the Veterans Affairs (VA) Center for Clinical Management Research and Michigan Medicine shared data on the largest PPI deprescribing intervention in Veterans, showing that these programs help reduce PPI prescribing, without increasing adverse events. Read more
Nancy Reau, MD, explored COVID-19-related liver disease in severe and long-term COVID-19 infections. Read more